Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening of Hepatocellular Carcinoma in Hepatic Cirrhosis Patients by a Novel Blood-Based Multi-Omics Test.

Technology in cancer research & treatment - 1 Jan 2026

Chen Lei, Liu Jun, Long Mengcheng, Hu Pinghai

Abstract excerpt

IntroductionHepatocellular carcinoma (HCC) screening in patients with hepatic cirrhosis (HC) relies on ultrasound and alpha-fetoprotein (US + AFP), which has limitations in sensitivity, particularly for early-stage HCC detection. This study aims to evaluate the performance of a novel multi-omics blood test, HCCscreen, with its individual components (methylation, AFP, Des-γ-Carboxy Prothrombin (DCP), mutations)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Fetoproteins
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Liver Cirrhosis

Share to Multiomics

Share to Protein Precursors

Share to Prothrombin

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 41869803
DOI: 10.1177/15330338261435022
PMCID: PMC13009828

Genes

AFP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening of Hepatocellular Carcinoma in Hepatic Cirrhosis Patients by a Novel Blood-Based Multi-Omics Test.PMID 41869803Read ↗

A Proposed AI/ML-Based Detection Framework for Early Detection of Hepatocellular Carcinoma (HCC) and CirrhosisSemantic proximity Read ↗

Clinical validation of peripheral blood mononuclear cell DNA methylation markers for accurate early detection of hepatocellular carcinoma in Asian patientsSemantic proximity Read ↗

Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort studySemantic proximity Read ↗

HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinomaSemantic proximity Read ↗

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical ValidationSemantic proximity Read ↗

DNA methylation fingerprint for the diagnosis and monitoring of hepatocellular carcinoma from tissue and liquid biopsiesSemantic proximity Read ↗

Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomicsSemantic proximity Read ↗

Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosisSemantic proximity Read ↗

DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsiesSemantic proximity Read ↗

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinomaSemantic proximity Read ↗

Exploring Hepatocellular Carcinoma Etiology through Multi-omics BioinformaticsSemantic proximity Read ↗

<i>epi</i>Liver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.